CIN-话题@MedSci

#CIN#

675篇内容 | 3166人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1774018, encodeId=7c291e7401810, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine：雄激素治疗对先天性角化不良患者血脂水平的影响, objectType=article, longId=292504, objectId=0e57292504e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e57292504e1, replyNumber=0, likeNumber=73, createdTime=2022-01-31, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e57292504e1, moduleTitle=EBioMedicine：雄激素治疗对先天性角化不良患者血脂水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e57292504e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774014, encodeId=ec951e7401461, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Phytomedicine：茯苓提取物通过调节脑肠肽、免疫、修复胃肠粘膜改善功能性消化不良, objectType=article, longId=292197, objectId=278029219efc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=278029219efc, replyNumber=0, likeNumber=79, createdTime=2022-05-02, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=278029219efc, moduleTitle=Phytomedicine：茯苓提取物通过调节脑肠肽、免疫、修复胃肠粘膜改善功能性消化不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=278029219efc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774034, encodeId=08311e74034bc, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=PLOS Medicine：改变你的饮食，可以延长十年寿命, objectType=article, longId=295440, objectId=a394295440c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a394295440c3, replyNumber=0, likeNumber=59, createdTime=2022-06-18, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a394295440c3, moduleTitle=PLOS Medicine：改变你的饮食，可以延长十年寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a394295440c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773988, encodeId=e7791e739889a, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, objectType=article, longId=215987, objectId=73ce21598e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ce21598e81, replyNumber=0, likeNumber=77, createdTime=2021-10-27, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ce21598e81, moduleTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ce21598e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774064, encodeId=30ba1e7406402, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Science Translational Medicine：帕金森病治疗的一大步：LRRK2抑制剂临床试验评估, objectType=article, longId=729619, objectId=4952e2961904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4952e2961904, replyNumber=0, likeNumber=65, createdTime=2022-12-16, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4952e2961904, moduleTitle=Science Translational Medicine：帕金森病治疗的一大步：LRRK2抑制剂临床试验评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4952e2961904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773990, encodeId=c2191e73990a0, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Preventive Medicine：超140万人群证实，儿童长期暴露于空气污染，自残风险增加50%！, objectType=article, longId=217366, objectId=ad0c21e36650, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad0c21e36650, replyNumber=0, likeNumber=75, createdTime=2022-01-22, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad0c21e36650, moduleTitle=Preventive Medicine：超140万人群证实，儿童长期暴露于空气污染，自残风险增加50%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad0c21e36650)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774062, encodeId=906f1e74062a8, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果, objectType=article, longId=727868, objectId=a22fe2786820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22fe2786820, replyNumber=0, likeNumber=67, createdTime=2023-03-22, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22fe2786820, moduleTitle=EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22fe2786820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773978, encodeId=bf1a1e7397815, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？, objectType=article, longId=214945, objectId=42612149451a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42612149451a, replyNumber=0, likeNumber=81, createdTime=2021-11-19, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42612149451a, moduleTitle=EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42612149451a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774047, encodeId=601e1e7404706, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度, objectType=article, longId=723794, objectId=1842e2379434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1842e2379434, replyNumber=0, likeNumber=115, createdTime=2022-10-19, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1842e2379434, moduleTitle=EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1842e2379434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773982, encodeId=22121e7398289, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Nature Medicine：CD19-CD22双靶点CAR-T临床试验结果发布, objectType=article, longId=215111, objectId=7ebf2151117e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ebf2151117e, replyNumber=0, likeNumber=82, createdTime=2022-01-04, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ebf2151117e, moduleTitle=Nature Medicine：CD19-CD22双靶点CAR-T临床试验结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ebf2151117e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774045, encodeId=14ba1e740458e, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine：非洲血统个体的血脂特征与2型糖尿病风险：孟德尔随机化研究, objectType=article, longId=723457, objectId=8b47e23457ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b47e23457ee, replyNumber=0, likeNumber=89, createdTime=2022-10-13, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b47e23457ee, moduleTitle=EBioMedicine：非洲血统个体的血脂特征与2型糖尿病风险：孟德尔随机化研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b47e23457ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774000, encodeId=2c4a1e74000d3, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, objectType=article, longId=218722, objectId=0a93218e222e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a93218e222e, replyNumber=0, likeNumber=86, createdTime=2022-06-18, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a93218e222e, moduleTitle=Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a93218e222e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774052, encodeId=d7ee1e740528a, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine：视网膜“再生”不是梦，干细胞技术功不可没, objectType=article, longId=724980, objectId=5e45e2498066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e45e2498066, replyNumber=0, likeNumber=68, createdTime=2022-06-25, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e45e2498066, moduleTitle=EBioMedicine：视网膜“再生”不是梦，干细胞技术功不可没, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e45e2498066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774055, encodeId=1fd01e74055be, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Science Translational Medicine：口服新冠疫苗，在第一道防线发挥保护作用，降低空气传播, objectType=article, longId=726479, objectId=e2dfe26479af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2dfe26479af, replyNumber=0, likeNumber=71, createdTime=2023-02-08, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2dfe26479af, moduleTitle=Science Translational Medicine：口服新冠疫苗，在第一道防线发挥保护作用，降低空气传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2dfe26479af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774061, encodeId=c7321e74061f5, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法, objectType=article, longId=728048, objectId=1cb1e28048ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cb1e28048ed, replyNumber=0, likeNumber=62, createdTime=2022-11-06, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cb1e28048ed, moduleTitle=EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cb1e28048ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774006, encodeId=dd041e74006c5, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌, objectType=article, longId=220793, objectId=d997220e93d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d997220e93d1, replyNumber=0, likeNumber=47, createdTime=2021-12-27, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d997220e93d1, moduleTitle=New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d997220e93d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774056, encodeId=8aaf1e7405668, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Int J Nanomedicine：倍他米松二丙酸酯-水杨酸纳米给药系统治疗头皮银屑病疗效分析, objectType=article, longId=726414, objectId=4172e2641405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4172e2641405, replyNumber=0, likeNumber=89, createdTime=2022-08-19, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4172e2641405, moduleTitle=Int J Nanomedicine：倍他米松二丙酸酯-水杨酸纳米给药系统治疗头皮银屑病疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4172e2641405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774044, encodeId=62871e74044a7, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=Phytomedicine：多组学方法观察真武补气汤对慢性结肠炎的治疗作用及机制, objectType=article, longId=723598, objectId=dfc1e23598d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc1e23598d3, replyNumber=0, likeNumber=63, createdTime=2022-12-25, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc1e23598d3, moduleTitle=Phytomedicine：多组学方法观察真武补气汤对慢性结肠炎的治疗作用及机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfc1e23598d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773977, encodeId=cfa71e73977ee, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=JAMA Internal Medicine：每天一杯咖啡，心律失常风险竟降低 3%？！, objectType=article, longId=214617, objectId=87b421461ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87b421461ed5, replyNumber=0, likeNumber=67, createdTime=2021-08-01, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87b421461ed5, moduleTitle=JAMA Internal Medicine：每天一杯咖啡，心律失常风险竟降低 3%？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87b421461ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1774027, encodeId=482c1e740276e, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, objectTitle=EBioMedicine：红细胞增多与IgA肾病有关, objectType=article, longId=294147, objectId=022329414ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022329414ebe, replyNumber=0, likeNumber=70, createdTime=2023-01-02, rootId=0, userName=kalseyzl, userId=a9a038523631, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022329414ebe, moduleTitle=EBioMedicine：红细胞增多与IgA肾病有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022329414ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CIN

2020-05-29

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine：雄激素治疗对先天性角化不良患者血脂水平的影响

2022-01-31

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Phytomedicine：茯苓提取物通过调节脑肠肽、免疫、修复胃肠粘膜改善功能性消化不良

2022-05-02

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

PLOS Medicine：改变你的饮食，可以延长十年寿命

2022-06-18

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病

2021-10-27

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Science Translational Medicine：帕金森病治疗的一大步：LRRK2抑制剂临床试验评估

2022-12-16

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Preventive Medicine：超140万人群证实，儿童长期暴露于空气污染，自残风险增加50%！

2022-01-22

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine ：CBP/β-连环蛋白抑制剂PRI-724在丙型和乙型肝炎病毒诱导的肝硬化患者中的安全性、耐受性和抗纤维化效果

2023-03-22

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EClinicalMedicine：国药新冠疫苗接种第3剂，中和抗体能达到什么水平？

2021-11-19

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度

2022-10-19

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Nature Medicine：CD19-CD22双靶点CAR-T临床试验结果发布

2022-01-04

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine：非洲血统个体的血脂特征与2型糖尿病风险：孟德尔随机化研究

2022-10-13

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Neurology : Neurofascin-155免疫球蛋白亚型，临床病理关联和神经结局

2022-06-18

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine：视网膜“再生”不是梦，干细胞技术功不可没

2022-06-25

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Science Translational Medicine：口服新冠疫苗，在第一道防线发挥保护作用，降低空气传播

2023-02-08

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法

2022-11-06

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

New England Journal of Medicine：尼拉帕利一线维持治疗晚期卵巢癌

2021-12-27

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Int J Nanomedicine：倍他米松二丙酸酯-水杨酸纳米给药系统治疗头皮银屑病疗效分析

2022-08-19

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

Phytomedicine：多组学方法观察真武补气汤对慢性结肠炎的治疗作用及机制

2022-12-25

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

JAMA Internal Medicine：每天一杯咖啡，心律失常风险竟降低 3%？！

2021-08-01

kalseyzl (审核中...)

前往app查看评论内容

#CIN#

EBioMedicine：红细胞增多与IgA肾病有关

2023-01-02

科室
- - 订阅+
  - 更多科室
工具
服务